Silverfin false false 31/10/2025 24/10/2024 31/10/2025 Dr K M Aku Ayivor-Nygard 24/10/2024 23 October 2026 no description of principal activity 16040141 2025-10-31 16040141 bus:Director1 2025-10-31 16040141 core:CurrentFinancialInstruments 2025-10-31 16040141 core:ShareCapital 2025-10-31 16040141 core:RetainedEarningsAccumulatedLosses 2025-10-31 16040141 core:OtherResidualIntangibleAssets 2024-10-23 16040141 2024-10-23 16040141 core:OtherResidualIntangibleAssets 2025-10-31 16040141 core:FurtherRelatedPartyRelationshipType2ComponentAllOtherRelatedParties core:CurrentFinancialInstruments 2025-10-31 16040141 1 2025-10-31 16040141 bus:OrdinaryShareClass1 2025-10-31 16040141 2024-10-24 2025-10-31 16040141 bus:FilletedAccounts 2024-10-24 2025-10-31 16040141 bus:SmallEntities 2024-10-24 2025-10-31 16040141 bus:AuditExemptWithAccountantsReport 2024-10-24 2025-10-31 16040141 bus:PrivateLimitedCompanyLtd 2024-10-24 2025-10-31 16040141 bus:Director1 2024-10-24 2025-10-31 16040141 core:OtherResidualIntangibleAssets core:TopRangeValue 2024-10-24 2025-10-31 16040141 core:OtherResidualIntangibleAssets 2024-10-24 2025-10-31 16040141 bus:OrdinaryShareClass1 2024-10-24 2025-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 16040141 (England and Wales)

ALULA THERAPY LTD

Unaudited Financial Statements
For the financial period from 24 October 2024 to 31 October 2025
Pages for filing with the registrar

ALULA THERAPY LTD

Unaudited Financial Statements

For the financial period from 24 October 2024 to 31 October 2025

Contents

ALULA THERAPY LTD

STATEMENT OF FINANCIAL POSITION

As at 31 October 2025
ALULA THERAPY LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 October 2025
Note 31.10.2025
£
Fixed assets
Intangible assets 3 14,880
14,880
Current assets
Debtors 4 4,855
Investments 5 3,000
7,855
Creditors: amounts falling due within one year 6 ( 24,600)
Net current liabilities (16,745)
Total assets less current liabilities (1,865)
Net liabilities ( 1,865)
Capital and reserves
Called-up share capital 7 20
Profit and loss account ( 1,885 )
Total shareholders' deficit ( 1,865)

For the financial period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Alula Therapy Ltd (registered number: 16040141) were approved and authorised for issue by the Director. They were signed on its behalf by:

Dr K M Aku Ayivor-Nygard
Director

23 October 2026

ALULA THERAPY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 24 October 2024 to 31 October 2025
ALULA THERAPY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 24 October 2024 to 31 October 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Alula Therapy Ltd (the company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 85 Wimpole Street, London, W1G 9RJ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings/Statement of Comprehensive Income.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2. Employees

Period from
24.10.2024 to
31.10.2025
Number
Monthly average number of persons employed by the company during the period, including the director 1

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 24 October 2024 0 0
Additions 18,600 18,600
At 31 October 2025 18,600 18,600
Accumulated amortisation
At 24 October 2024 0 0
Charge for the financial period 3,720 3,720
At 31 October 2025 3,720 3,720
Net book value
At 31 October 2025 14,880 14,880

4. Debtors

31.10.2025
£
Amounts owed by connected companies 4,706
Other debtors 149
4,855

5. Current asset investments

31.10.2025
£
Unlisted investment 3,000

6. Creditors: amounts falling due within one year

31.10.2025
£
Other taxation and social security 1,335
Other creditors 23,265
24,600

7. Called-up share capital

31.10.2025
£
Allotted, called-up and fully-paid
2,000 Ordinary shares of £ 0.01 each 20

8. Related party transactions

Included within other debtors of £4,706 are balances owed to a company in which the director has an interest as director and participator.

Included within other creditors of £20,865 are balances owed to the director.